M&A Deal Summary

Sigma-Aldrich Acquires Molecular Medicine Bioservices

On May 8, 2007, Sigma-Aldrich acquired life science company Molecular Medicine Bioservices

Acquisition Highlights
  • This is Sigma-Aldrich’s 6th transaction in the Life Science sector.
  • This is Sigma-Aldrich’s 3rd transaction in the United States.
  • This is Sigma-Aldrich’s 1st transaction in California.

M&A Deal Summary

Date 2007-05-08
Target Molecular Medicine Bioservices
Sector Life Science
Buyer(s) Sigma-Aldrich
Deal Type Add-on Acquisition

Target

Molecular Medicine Bioservices

Carlsbad, California, United States
Molecular Medicine Bioservices, Inc. is a biopharmaceutical contract manufacturing organization to further enhance the biologics capabilities within its SAFC Pharma business segment.

Search 177,782 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Sigma-Aldrich

St. Louis, Missouri, United States

website


Category Company
Founded 1951
Sector Life Science
Employees9,800
Revenue 2.8B USD (2014)
DESCRIPTION

Sigma-Aldrich Corp. is a life science and high technology company whose biochemical, organic chemical products, kits, and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university, and government institutions, hospitals, and industry.


DEAL STATS #
Overall 6 of 13
Sector (Life Science) 6 of 10
Type (Add-on Acquisition) 4 of 9
State (California) 1 of 2
Country (United States) 3 of 9
Year (2007) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2006-08-09 Pharmorphix

Cambridge, United Kingdom

Pharmorphix Ltd. is a provider of solid form services, including polymorph studies, salt selection, co-crystallization, chiral separations and process scale up that are critical to successful drug discovery and development.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-08-07 ChemNavigator

Milwaukee, Wisconsin, United States

ChemNavigator, Inc. is a provider of drug discovery using proprietary proteomics and cheminformatics technologies, called 3-DPL™ Map and ChemMatrix™.

Buy -